Product NDC: | 42195-550 |
Proprietary Name: | Ciprofloxacin Otic |
Non Proprietary Name: | CIPROFLOXACIN |
Active Ingredient(s): | .5 mg/.25mL & nbsp; CIPROFLOXACIN |
Administration Route(s): | AURICULAR (OTIC) |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42195-550 |
Labeler Name: | Xspire Pharma |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021918 |
Marketing Category: | NDA |
Start Marketing Date: | 20120827 |
Package NDC: | 42195-550-14 |
Package Description: | 14 CONTAINER in 1 CARTON (42195-550-14) > .25 mL in 1 CONTAINER |
NDC Code | 42195-550-14 |
Proprietary Name | Ciprofloxacin Otic |
Package Description | 14 CONTAINER in 1 CARTON (42195-550-14) > .25 mL in 1 CONTAINER |
Product NDC | 42195-550 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CIPROFLOXACIN |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | AURICULAR (OTIC) |
Start Marketing Date | 20120827 |
Marketing Category Name | NDA |
Labeler Name | Xspire Pharma |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/.25mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |